Amber Michalik — Baltimore, Maryland

Amber Michalik is a clinical research site located in Baltimore, Maryland, United States 20707.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Amber Michalik has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Prostate Adenocarcinoma, Metastatic Prostate Adenocarcinoma, Castration-resistant.

Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Amber Michalik?

Amber Michalik has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Amber Michalik conducted?

Amber Michalik has 1 clinical trials on record, with 1 currently active. Their work covers Prostate Adenocarcinoma, Metastatic Prostate Adenocarcinoma, Castration-resistant.

Is Amber Michalik accredited by Crixeo Health?

Amber Michalik has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Amber Michalik?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.